Abstract
Human leukocyte antigen (HLA) plays a critical role in innate and adaptive immunity and is a well-known example of genes under natural selection. However, the genetic aspect of receptors recognizing HLA molecules has not yet been fully elucidated. Leukocyte immunoglobulin (Ig)-like receptors (LILRs) are a family of HLA class I-recognizing receptors comprising activating and inhibitory forms. We previously reported that the allele frequency of the 6.7 kb LILRA3 deletion is extremely high (71%) in the Japanese population, and we identified premature termination codon (PTC)-containing alleles. In this study, we observed a wide distribution of the high deletion frequency in Northeast Asians (84% in Korean Chinese, 79% in Man Chinese, 56% in Mongolian, and 76% in Buryat populations). Genotyping of the four HapMap populations revealed that LILRA3 alleles were in strong linkage disequilibrium with LILRB2 alleles in Northeast Asians. In addition, PTC-containing LILRA3 alleles were detected in Northeast Asians but not in non-Northeast Asians. Furthermore, flow-cytometric analysis revealed that the LILRB2 allele frequent in Northeast Asians was significantly associated with low levels of expression. FST and extended-haplotype-homozygosity analysis for the HapMap populations provided evidence of positive selection acting on the LILRA3 and LILRB2 loci. Taken together, our results suggest that both the nonfunctional LILRA3 alleles and the low-expressing LILRB2 alleles identified in our study have increased in Northeast Asians because of natural selection. Our findings, therefore, lead us to speculate that not only HLA class I ligands but also their receptors might be sensitive to the local environment.
Introduction
Human leukocyte antigen (HLA) genes are well-known examples of genes under natural selection.1 HLA molecules play a critical role in innate and adaptive immunity by acting as self-markers recognized by HLA class I receptors—such as leukocyte immunoglobulin (Ig)-like receptor (LILR), killer cell Ig-like receptor (KIR), and NKG2—or by presenting self and nonself peptides to T cell receptors. Because of evolutionary and functional significance of the HLA genes, numerous studies have demonstrated strong associations between HLA alleles and autoimmune or infectious diseases. However, to date, the genetic aspects of receptors recognizing HLA molecules are not fully understood.
Leukocyte immunoglobulin (Ig)-like receptors (LILRs) are a multigene family of HLA class I-recognizing receptors.2 The LILR family comprises 11 expressed genes and two pseudogenes. LILRs consist of activating (LILRA1-6) and inhibitory (LILRB1-5) receptors expressed mainly on the myeloid cells, although some LILRs are expressed on lymphoid cells. Both LILRB1 and LILRB2 bind to a broad range of classical and nonclassical HLA class I molecules and inhibit the stimulatory signals triggered via activating receptors. This suggests that not only NK cells and T cells, but also other cells expressing LILR, are able to monitor the cell-surface expression of HLA class I molecules.3,4 Numerous studies have shown that the LILR genes are highly polymorphic and that they have accumulated disease-associated polymorphisms.5–14 On the other hand, the murine homolog of LILR is thought to be the paired Ig-like receptor (PIR), which consists of activating (PIR-A) and inhibitory (PIR-B) forms. PIR can also bind to various mouse major histocompatibility complex (MHC) class I molecules. In addition, PIR-B-deficient mice exhibit aberrant B cell activation, impaired dendritic cell maturation, increased T helper cell 2 (Th2) responses, and exacerbated graft-versus-host disease.15,16
LILRA3 [MIM 604818] is unique among LILRs in that the gene exhibits a presence or absence variation due to a 6.7-kb deletion6,7,9,17 and encodes a secreted protein.18–20 We have previously described the allele frequency of the 6.7-kb LILRA3 deletion as extremely high (71%) in the Japanese population as compared with the Thai, African, and European-descended populations.13 Furthermore, we identified a splice-acceptor mutation in intron 1 resulting in three alternatively spliced isoforms with premature-termination codons (PTCs) in exon 3, thus suggesting that natural selection has acted on the LILRA3 gene. However, it cannot be ruled out that these observations suggest a hitchhiking effect of variations in genes closely linked to LILRA3. Accordingly, the aims of this study are to examine the geographical distribution of variations in the LILRA3 region for the Northeast Asian and HapMap populations and to investigate the evolutionary and functional significance of the LILRA3 and adjacent genes.
Material and Methods
Genomic DNA Samples
Genomic DNA samples from four healthy, unrelated Northeast Asian volunteers, including 49 Korean (in China), 47 Man (in China), 47 Mongolian, and 48 Buryat individuals, were previously collected for the study of HLA polymorphisms.21–23 The genomic DNA samples used by the International HapMap Project were obtained from the Coriell Cell Repository: 44 individuals from the Japanese population in Tokyo (JPT), 45 individuals from the Han Chinese population in Beijing (CHB), 59 individuals (parents) from the Centre d'Etude du Polymorphisme Humain (CEPH) collection (CEU), and 58 individuals (parents) from the Yoruba population in Ibadan, Nigeria (YRI). This study was reviewed and approved by the research-ethics committees of the Tokyo Metropolitan Red Cross Blood Center and the Faculty of Medicine of the University of Tokyo.
Genotyping of the LILRA3 and LILRB2 Genes
An LILRA3-deletion polymorphism was genotyped by the PCR-SSP typing method, and the splice-acceptor mutation at nucleotide position 161 of intron 1, which causes PTC in exon 3, was detected by the sequencing-based typing method in Northeast Asian and HapMap populations, performed as described previously.13 Direct sequencing of the LILRB2 gene in the HapMap populations focused on the functional regions including the 568-bp promoter region, the 5′-untranslated region (UTR), the signal sequence region, four Ig-like domains, the cytoplasmic domain, and the 3′-UTR. Nomenclature of sequence variations was based on the recommendations of the Human Genome Variation Society (HGVS). Primer information is shown in Table 1. First, four amplicons for sequencing were produced by PCR with each set of primers, then sequenced by each sequencing primer. Direct sequencing was carried out with an ABI PRISM 3100 Genetic Analyzer (Foster City, CA, USA). Derived alleles were determined by sequence alignment for LILRB2 and chimpanzee LIRb (LILRB2 homolog) with the use of CLUSTAL W on MEGA3 software.24 LILRB2 (accession no. NC_000019.8 ranging from 59470132 to 59476762 of reverse complemented strand) and LIRb (accession no. NC_006486.2 ranging from 59981107 to 59987522 of reverse complemented strand) sequences were obtained from NCBI.
Table 1.
Method | Primer Name | Sequence (5′ → 3′) |
---|---|---|
PCR (Amplicon 1) | Promoter-f-A | TGCTACACATACGTTTCTCCATTAC |
Intron1-r | CAAATAGAACTGGTGCTTCTTGT | |
Sequencing (Amplicon 1) | Promoter-f-A | TGCTACACATACGTTTCTCCATTAC |
Promoter-r | CCGGGAAGAAACCTCTGAGT | |
Promoter-f-B | GGTGCAGAGGGACGGCTAAGGAC | |
Intron1-r | CAAATAGAACTGGTGCTTCTTGT | |
PCR (Amplicon 2) | Intron1-f | CCAGCCTCTGAGTGTCCACACA |
Intron5-r | GAGACTCAGGGAACTCCAGA | |
Sequencing (Amplicon 2) | Intron1-f | CCAGCCTCTGAGTGTCCACACA |
Intron3-r | TCCCCATCCCCAGCTGCACGGA | |
Intron3-f | CAGCTGGGGATGGGGATTAGA | |
Intron4-r | GGAGACACCCCTGAGAGCCT | |
Intron4-f | GCTCTGCCCTCAGGAAGGA | |
Intron5-r | GAGACTCAGGGAACTCCAGA | |
PCR (Amplicon 3) | Intron5-f | AAGATCAGCAGTGGTGAGGCA |
Intron7-r-A | TGCTGGCGATGCCGCTGAGTGTGC | |
Sequencing (Amplicon 3) | Intron5-f | AAGATCAGCAGTGGTGAGGCA |
Intron6-r | GACCACCCCCCGCCTCATCCT | |
Intron6-f | AGAAAACAGAGACAGAGGCTCCTA | |
Intron7-r-B | CCCACTGGCTGAGCCCCG | |
PCR (Amplicon 4) | Intron13-f-A | ACAAAATGCAAATAAATGCGCCA |
UTR-r | TGATTTTAGTTTTCTCGGTTAAC | |
Sequencing (Amplicon 4) | Intron13-f-B | AGGACAGACAGATGGACACTGAGA |
UTR-r | TGATTTTAGTTTTCTCGGTTAAC |
Flow-Cytometric Analysis
Whole blood samples derived from twenty-one healthy Japanese individuals were stained with PE-conjugated monoclonal human CD85d (ILT4/LILRB2) antibody (Beckman Coulter), and this was followed by the lysing of red blood cells with OptiLyse C Lysis Solution (Beckman Coulter). Cell preparations were analyzed on a FC500 flow cytometer (Beckman Coulter). Mann-Whitney U test was used for the assessment of differences in cell-surface expression levels of LILRB2 between genotypes.
Data Analysis
The HapMap Phase II genotype data and our genotyping data of LILRA3 and LILRB2 in the HapMap populations were used in the following analyses. Linkage disequilibrium (LD) parameters (D′ and r2) and haplotype frequencies were estimated with the Haploview program.
We used the FST statistic for evaluation of the population differentiation at the LILRA3 and LILRB2 loci. For generation of the empirical distributions of FST between Northeast Asian (JPT and CHB, denoted hereafter as “JPT+CHB”) and European (CEU) populations and between Northeast Asian (JPT+CHB) and African (YRI) populations, the FST statistic was applied to 40,072 SNPs on chromosome 19, which included polymorphic SNPs in the four HapMap populations, extracted by removal of monomorphic SNPs in all of the HapMap populations from the HapMap Phase II data. Values beyond the 95th percentile were regarded as significant.
Extended haplotype homozygosity (EHH)25 was calculated for the detection of evidence of positive selection acting on the LILRA3 and LILRB2 genes. EHH at a distance of “x” from the core region is defined as the probability that two randomly chosen chromosomes from the samples carrying a tested core haplotype are homozygous at all SNPs for the entire interval from the core region to x. Relative EHH (REHH) is the ratio of the EHH on the tested core haplotype to the EHH of the grouped set of core haplotypes at the region not including the core haplotype tested. First, we inserted our genotype data into the HapMap Phase II SNP data on chromosome 19, and the haplotype phase was then estimated for the entire chromosome with the fastPHASE v.1.2.3 program.26 The phased data was used for EHH analysis, implemented in the SWEEP v1.1 program, on our tested core haplotypes. REHH was calculated at a 0.25 cM distance from the core on both sides. For assessment of statistical significance, the empirical data were divided equally into 20 bins on the basis of haplotype frequencies, and the REHH values for the tested core haplotypes were ranked within the bin. Values beyond the 95th percentile were regarded as significant.
Results
Wide Distribution of Nonfunctional LILRA3 Alleles in Northeast Asians
A 6.7 kb LILRA3 deletion and splice-acceptor mutation of intron 1 were genotyped in four Northeast Asian population samples and in four HapMap population samples. Table 2 shows the allele frequencies of LILRA3 in various populations, including the eight populations examined in this study. The allele frequencies of the 6.7 kb LILRA3 deletion were found to be remarkably high in all of the Northeast Asian samples, with the highest allele frequency seen in the Korean population samples. On the other hand, the allele frequencies of the 6.7-kb LILRA3 deletion in the CEU and YRI population samples were low, which is consistent with the frequencies in non-Northeast Asians that were reported in a previous study.17 It should be noted that PTC-containing alleles were widely present in Northeast Asian samples but were not detected in CEU or YRI samples. As shown in Figure 1, nonfunctional LILRA3 alleles, including the 6.7-kb deletion and PTC-containing alleles, were predominant in Northeast Asians.
Table 2.
No. | Population | N | Deletion | PTC | Functional |
---|---|---|---|---|---|
1 | Koreana | 49 | 0.84 | 0.13 | 0.03 |
2 | Mana | 47 | 0.79 | 0.05 | 0.16 |
3 | Mongoliana | 47 | 0.56 | 0.14 | 0.30 |
4 | Buryata | 48 | 0.76 | 0.02 | 0.22 |
5 | Japanese13 | 119 | 0.71 | 0.19 | 0.10 |
6 | JPTa | 44 | 0.78 | 0.11 | 0.11 |
7 | CHBa | 45 | 0.70 | 0.11 | 0.19 |
8 | CEUa | 59 | 0.17 | 0 | 0.83 |
9 | YRIa | 58 | 0.07 | 0 | 0.93 |
10 | Palestinian17 | 100 | 0.10 | 0 | 0.90 |
11 | Caucasoid (UK)17 | 172 | 0.26 | 0 | 0.74 |
12 | Thai17 | 119 | 0.21 | 0 | 0.79 |
13 | Pakistani17 | 92 | 0.10 | 0 | 0.90 |
this study.
Variations of the LILRB2 Gene and Structure of LD
For examination of LD between LILRA3 and adjacent genes, the HapMap database was used. Although no strong LD was observed between LILRA3 and adjacent genes, the extent of LD between LILRA3 and LILRB2 (MIM 604815) could not be determined because there was no informative SNP data on LILRB2 in the HapMap database. Thus, we searched for variations of the LILRB2 gene with direct sequencing of the genomic region corresponding to functional domains such as the 568-bp promoter, 5′-UTR, signal peptide, four Ig-like domain, cytoplasmic domain, and 3′-UTR in all of the HapMap samples used in this study. Of the identified SNPs, four were markedly differentiated between Northeast Asians (JPT+CHB) and non-Northeast Asians (CEU, YRI) (Figure 2 and Table 3). Two SNPs were located in the 5′-UTR (c.−169G→A rs448092 and c.−153G→A rs448083), and the other two were nonsynonymous SNPs located in the signal sequence (c.59A→G, p.R20H rs383369) and the third Ig-like domain (c.703G→A, p.M235V rs386056). Haplotype frequencies are shown in Table 4. Strong LD was observed between the LILRA3-deletion polymorphism and the four LILRB2 SNPs, whereas LILRA3 and LILRB2 were not in strong LD with the other adjacent genes (Figure 3).
Table 3.
Derived Allele Frequencies |
|||||
---|---|---|---|---|---|
SNP | JPT | CHB | CEU | YRI | Derived Allele |
c.−169G→A | 0.81 | 0.80 | 0.15 | 0.09 | A |
c.−153G→A | 0.81 | 0.80 | 0.14 | 0.03 | A |
c.59A→G | 0.81 | 0.81 | 0.14 | 0.03 | G |
c.703G→A | 0.82 | 0.82 | 0.14 | 0.09 | A |
Table 4.
Haplotypea | JPT | CHB | CEU | YRI |
---|---|---|---|---|
AGAA | 0.814 | 0.789 | 0.144 | 0.026 |
GAGG | 0.186 | 0.166 | 0.847 | 0.914 |
AGGG | 0 | 0.023 | 0 | 0 |
AAGA | 0 | 0 | 0 | 0.060 |
Haplotype names refer to the alleles of the four SNPs in order from left to right; c.703G→A, c.59A→G, c.−153G→A, and c.−169G→A.
LILRB2 Genotypes and Cell-Surface Expression
The three notable LILRB2 polymorphisms were located in the 5′-UTR and the signal sequence region, both of which potentially influence its expression. Thus, we investigated whether the LILRB2 genotypes were associated with cell-surface expression by using flow cytometry. Given that LILRB2 is mainly expressed on monocytes, myelomonocytic cells were gated on the basis of forward- and side-scatter parameters and examined for LILRB2 cell-surface expression in 21 individuals. As shown in Figure 4, the c.59G allele, common in Northeast Asians, was significantly associated with low expression levels of LILRB2. In our samples, the c.−169A and c.−153A alleles gave the same results as the c.59G allele because of absolute LD (r2 = 1). In this regard, however, it cannot be ruled out that the present association came from the LD with the primary SNPs that were not examined in this study.
Evidence for the Acting of Positive Selection on the LILRA3 and LILRB2 Genes in Northeast Asians
On the basis of the above data, we hypothesized that natural selection acted on LILRA3 and LILRB2 in Northeast Asians. It is possible to distinguish between the consequences of genetic drift and of natural selection without invoking any assumptions regarding population demography by comparing the FST of individual loci with empirical genome-wide distribution.27 Thus, to test our hypothesis, we constructed the empirical distribution of FST for all of the SNPs on chromosome 19 in the HapMap data and then compared this with the FST values for the nonfunctional LILRA3 polymorphism and four LILRB2 SNPs. Figures 5A and 5B show the empirical distribution of FST between Northeast Asian and European samples and between Northeast Asian and African samples, respectively. The FST values for the nonfunctional LILRA3 polymorphism and four LILRB2 SNPs were significantly differentiated both between Northeast Asian and European samples and between Northeast Asian and African samples (Figure 5). Each polymorphism exhibited similar FST values because of strong LD (Table 5). Although several SNPs in genes closely linked to LILRA3 and LILRB2 also showed significant FST values, the LILRA3 and LILRB2 regions exhibited the highest FST values, as compared with the other adjacent region (Table 5).
Table 5.
FST Value (Percentile) |
||
---|---|---|
Polymorphism | JPT+CHB versus CEU | JPT+CHB versus YRI |
LILRA3 | ||
(functional/nonfunctional) | 0.48 (99.9th) | 0.65 (99.9th) |
LILRB2 | ||
c.−169G→A (rs448092) | 0.42 (99.9th) | 0.52 (99.5th) |
c.−153G→A (rs448083) | 0.44 (99.9th) | 0.62 (99.8th) |
c.59A→G (rs383369) | 0.44 (99.9th) | 0.63 (99.8th) |
c.703G→A (rs386056) | 0.46 (99.9th) | 0.54 (99.6th) |
Downstresm of LILRB2 (close to LILRB5) | ||
rs7409450 | 0.37 (99.8th) | 0.42 (98.7th) |
Upstream of LILRA3 (close to LILRA5) | ||
rs651279 | 0.27 (98.8th) | 0.62 (99.8th) |
rs1761455 | 0.27 (98.8th) | 0.62 (99.8th) |
The SNPs adjacent to LILRB5 and LILRA5, of which FST values exceeded the 95th percentile in both JPT+CHB versus CEU and JPT+CHB versus YRI, are shown.
It is well known that recent positive selection could leave an imprint on human genome as extended LD.25,28 Thus, we applied the EHH analysis proposed by Sabeti et al.25 to our data. We selected three LILRB2 SNPs (c.59A→G, c.−153G→A, and c.−169G→A) as the core region because the GAA haplotype was considered to be the selected candidate haplotype on the basis of the expression data above. As shown in Figures 6A and 6B, REHH values of the LILRA3 core haplotype C-del-C (derived from rs410852, LILRA3-deletion polymorphism, and rs7252525) and the LILRB2 core haplotype GAA increased upstream of the core, and the REHH values at 0.25 cM were significant in the same frequency bin (REHH = 8.47 [96.7th percentile], 5.37 [95.7th percentile]; Figures 6C and 6D, respectively). On the other hand, the REHH values of the corresponding haplotypes for CEU (LILRA3: rs410852-LILRA3 deletion polymorphism-rs7252525, LILRB2: rs383369-rs448083-rs448092) and YRI (LILRA3: rs10412494-LILRA3 deletion polymorphism-rs7252525, LILRB2: rs383369-rs448083-rs448092) were not significant (at < 95th percentile). To gain a better understanding of the relative significance of the LILRA3 and LILRB2 alleles, we performed EHH analysis on the adjacent SNPs (close to LILRB5 and LILRA5) with high FST values, shown in Table 5. However, none of these SNPs showed significant REHH value (at < 95th percentile). These data suggest that LILRA3 and LILRB2 are the potential regions under natural selection in Northeast Asians.
Discussion
In an earlier study, FST analysis of the LILRA3 alleles was performed on populations including Thai, Palestinian, African, and European-descended;17 however, Northeast Asians have not yet been examined. In this study, we showed that remarkably high frequencies of nonfunctional LILRA3 and low-expressing LILRB2 alleles identified in our study were observed in Northeast Asians and significant FST values were obtained in the empirical distributions of FST. Moreover, PTC-containing alleles were detected in Northeast Asian populations, but not in the other populations examined. Similarly, polymorphisms in another HLA class I receptor, KIR, also have the unique characteristics found in Northeast Asians: KIR shows extensive genetic variability,29,30 and Northeast Asians have a high frequency of the group A KIR haplotype with less activating forms.31–36 Given that no significant LD was observed between LILRA3 and KIR,17 the group A KIR haplotype and nonfunctional LILRA3 and low-expressing LILRB2 alleles might have been independently increased in Northeast Asians due to natural selection. Considering that both KIR and LILR are members of the HLA class I-recognizing receptor family, the HLA-receptor system might be sensitive to the local environment and could be important for pathogen-host interaction. Therefore, it will be interesting in the future to examine the LILRA3 and LILRB2 alleles and their functions in the different populations.
One speculative mechanism for the acting of natural selection on LILRB2 is that LILRB2 might have been used for the entry of some type of pathogen endemic present or past in Northeast Asia. It is known that deficiency of Duffy antigen prevents Plasmodium vivax from invading erythrocytes and has a high FST value in humans, which is suggestive of natural selection.37 Therefore, low-expressing LILRB2 might be advantageous against some type of pathogen. Alternatively, Th1/Th2 balance might be important for the clearance of pathogen. PIR-B-deficient mice showed skewed Th2 responses, increasing interleukin 4 production, and decreasing interferon γ production.15 Furthermore, LILRA2 was upregulated in lesions of lepromatous patients and suppressed innate host defense by shifting cytokine production from interleukin-12 toward interleukin-10 and blocking antimicrobial activity triggered by Toll-like receptors.38 Thus, LILRB2 expression might be involved in regulating Th1/Th2 balance, and skewed Th1/Th2 balance might be advantageous against some pathogen. In addition, LILRB2 is the major receptor for HLA-G, the expression of which is restricted to placental cytotrophoblasts.39 Evidence of balancing selection at the HLA-G promoter region has been reported, and low-expressing HLA-G haplotypes might be favored in the presence of infection during pregnancy,40 which suggests that the level of interaction between HLA-G and LILRB2 expressed on decidual macrophages is important in some environment. Finally, recent studies have shown that PIR-B, LILRB1, and LILRB3 could directly recognize bacteria,41 and cytotoxic T cell lymphocyte escape mutations of HIV-1 could increase recognition of peptide-HLA class I complexes by LILRB2, leading to functional impairment of myelomonocytic cells.42 Hence, low-expressing LILRB2 might be able to prevent immune evasion from some type of pathogen.
On the other hand, it is difficult to explain how natural selection has operated to increase nonfunctional LILRA3 alleles in Northeast Asians, because the function of LILRA3 is still unknown. It has been speculated that LILRA3 could act as an antagonist of the other LILRs or as a soluble ligand to other receptors.43 Recent preliminary experimentation has shown that recombinant LILRA3 stimulated the proliferation of T cells in a mixed-lymphocyte reaction,44 thus suggesting that LILRA3 regulates T cell response. Alternatively, given that LILRA3 deficiency was significantly associated with multiple sclerosis (MS)11 and significant Th1 shift was seen in MS patients,45 LILRA3 might also regulate Th1/Th2 balance. In this regard, LILRA3 might function in concert with LILRB2, given that strong LD was observed between LILRA3 and LILRB2.
In conclusion, we found that nonfunctional LILRA3 and low-expressing LILRB2 alleles identified in our study were predominant in Northeast Asians and that these polymorphisms were significantly differentiated between Northeast Asians and non-Northeast Asians, as compared with the other genomic loci. Furthermore, the LILRA3 and LILRB2 core haplotypes showed significant long-range homozygosity. Taken together, these data provide evidence of natural selection operating on LILRA3 and LILRB2 in Northeast Asians. Although the causative agents for natural selection are unclear, our results will offer clues to a better understanding of the biological significance of the HLA-receptor system.
Web Resources
The URLs for data presented herein are as follows:
Haploview program, http://www.broad.mit.edu/mpg/haploview/
HapMap, http://www.hapmap.org/
HGVS, http://www.hgvs.org/
Online Mendelian Inheritance of Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/
SWEEP program, http://www.broad.mit.edu/mpg/sweep/
Acknowledgments
The authors would like to thank Ken-ichi Ogasawara and Motoko Nishimura (Central Blood Institute, Japanese Red Cross Society) for technical advice, Ryosuke Kimura (Tokai University School of Medicine) for valuable suggestions and discussion, and Akihiro Fujimoto and Daiki Yamashita (Department of Human Genetics, Graduate School of Medicine, University of Tokyo) for data analysis. We thank three anonymous reviewers for valuable comments and suggestions on a previous version of this manuscript. This study was partly supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.
References
- 1.Meyer D., Thomson G. How selection shapes variation of the human major histocompatibility complex: A review. Ann. Hum. Genet. 2001;65:1–26. doi: 10.1046/j.1469-1809.2001.6510001.x. [DOI] [PubMed] [Google Scholar]
- 2.Brown D., Trowsdale J., Allen R. The LILR family: Modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens. 2004;64:215–225. doi: 10.1111/j.0001-2815.2004.00290.x. [DOI] [PubMed] [Google Scholar]
- 3.Colonna M., Nakajima H., Navarro F., Lopez-Botet M. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J. Leukoc. Biol. 1999;66:375–381. doi: 10.1002/jlb.66.3.375. [DOI] [PubMed] [Google Scholar]
- 4.Fanger N.A., Borges L., Cosman D. The leukocyte immunoglobulin-like receptors (LIRs): A new family of immune regulators. J. Leukoc. Biol. 1999;66:231–236. doi: 10.1002/jlb.66.2.231. [DOI] [PubMed] [Google Scholar]
- 5.Heinzmann A., Blattmann S., Forster J., Kuehr J., Deichmann K.A. Common polymorphisms and alternative splicing in the ILT3 gene are not associated with atopy. Eur. J. Immunogenet. 2000;27:121–127. doi: 10.1046/j.1365-2370.2000.00214.x. [DOI] [PubMed] [Google Scholar]
- 6.Wilson M.J., Torkar M., Haude A., Milne S., Jones T., Sheer D., Beck S., Trowsdale J. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc. Natl. Acad. Sci. USA. 2000;97:4778–4783. doi: 10.1073/pnas.080588597. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Torkar M., Haude A., Milne S., Beck S., Trowsdale J., Wilson M.J. Arrangement of the ILT gene cluster: A common null allele of the ILT6 gene results from a 6.7-kbp deletion. Eur. J. Immunol. 2000;30:3655–3662. doi: 10.1002/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y. [DOI] [PubMed] [Google Scholar]
- 8.Young N.T., Canavez F., Uhrberg M., Shum B.P., Parham P. Conserved organization of the ILT/LIR gene family within the polymorphic human leukocyte receptor complex. Immunogenetics. 2001;53:270–278. doi: 10.1007/s002510100332. [DOI] [PubMed] [Google Scholar]
- 9.Norman P.J., Carey B.S., Stephens H.A., Vaughan R.W. DNA sequence variation and molecular genotyping of natural killer leukocyte immunoglobulin-like receptor, LILRA3. Immunogenetics. 2003;55:165–171. doi: 10.1007/s00251-003-0561-1. [DOI] [PubMed] [Google Scholar]
- 10.Papanikolaou N.A., Vasilescu E.R., Suciu-Foca N. Novel single nucleotide polymorphisms in the human immune inhibitory immunoglobulin-like T cell receptor type 4. Hum. Immunol. 2004;65:700–705. doi: 10.1016/j.humimm.2004.04.003. [DOI] [PubMed] [Google Scholar]
- 11.Koch S., Goedde R., Nigmatova V., Epplen J.T., Muller N., de Seze J., Vermersch P., Momot T., Schmidt R.E., Witte T. Association of multiple sclerosis with ILT6 deficiency. Genes Immun. 2005;6:445–447. doi: 10.1038/sj.gene.6364187. [DOI] [PubMed] [Google Scholar]
- 12.Kuroki K., Tsuchiya N., Shiroishi M., Rasubala L., Yamashita Y., Matsuta K., Fukazawa T., Kusaoi M., Murakami Y., Takiguchi M. Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis. Hum. Mol. Genet. 2005;14:2469–2480. doi: 10.1093/hmg/ddi247. [DOI] [PubMed] [Google Scholar]
- 13.Hirayasu K., Ohashi J., Kashiwase K., Takanashi M., Satake M., Tokunaga K., Yabe T. Long-term persistence of both functional and non-functional alleles at the leukocyte immunoglobulin-like receptor A3 (LILRA3) locus suggests balancing selection. Hum. Genet. 2006;119:436–443. doi: 10.1007/s00439-006-0152-y. [DOI] [PubMed] [Google Scholar]
- 14.Tsuchiya N., Kyogoku C., Miyashita R., Kuroki K. Diversity of human immune system multigene families and its implication in the genetic background of rheumatic diseases. Curr. Med. Chem. 2007;14:431–439. doi: 10.2174/092986707779941041. [DOI] [PubMed] [Google Scholar]
- 15.Ujike A., Takeda K., Nakamura A., Ebihara S., Akiyama K., Takai T. Impaired dendritic cell maturation and increased TH2 responses in PIR-B−/− mice. Nat. Immunol. 2002;3:542–548. doi: 10.1038/ni801. [DOI] [PubMed] [Google Scholar]
- 16.Nakamura A., Kobayashi E., Takai T. Exacerbated graft-versus-host disease in Pirb−/− mice. Nat. Immunol. 2004;5:623–629. doi: 10.1038/ni1074. [DOI] [PubMed] [Google Scholar]
- 17.Norman P.J., Cook M.A., Carey B.S., Carrington C.V., Verity D.H., Hameed K., Ramdath D.D., Chandanayingyong D., Leppert M., Stephens H.A. SNP haplotypes and allele frequencies show evidence for disruptive and balancing selection in the human leukocyte receptor complex. Immunogenetics. 2004;56:225–237. doi: 10.1007/s00251-004-0674-1. [DOI] [PubMed] [Google Scholar]
- 18.Arm J.P., Nwankwo C., Austen K.F. Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor. J. Immunol. 1997;159:2342–2349. [PubMed] [Google Scholar]
- 19.Borges L., Hsu M.L., Fanger N., Kubin M., Cosman D. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J. Immunol. 1997;159:5192–5196. [PubMed] [Google Scholar]
- 20.Colonna M., Navarro F., Bellon T., Llano M., Garcia P., Samaridis J., Angman L., Cella M., Lopez-Botet M. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 1997;186:1809–1818. doi: 10.1084/jem.186.11.1809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Tokunaga K., Sideltseva E.W., Tanaka H., Uchikawa C., Nieda M., Sideltsev V.V., Zhuravleva E., Imanishi T., Itoh K., Akaza T. Distribution of HLA antigens and haplotypes in the Buryat population of Siberia. Tissue Antigens. 1995;45:98–102. doi: 10.1111/j.1399-0039.1995.tb02424.x. [DOI] [PubMed] [Google Scholar]
- 22.Chimge N.O., Tanaka H., Kashiwase K., Ayush D., Tokunaga K., Saji H., Akaza T., Batsuuri J., Juji T. The HLA system in the population of Mongolia. Tissue Antigens. 1997;49:477–483. doi: 10.1111/j.1399-0039.1997.tb02782.x. [DOI] [PubMed] [Google Scholar]
- 23.Ogawa A., Tokunaga K., Lin L., Kashiwase K., Tanaka H., Herrero M.J., Vilches C., Park M.H., Jia G.J., Chimge N.O. Diversity of HLA-B61 alleles and haplotypes in East Asians and Spanish Gypsies. Tissue Antigens. 1998;51:356–366. doi: 10.1111/j.1399-0039.1998.tb02974.x. [DOI] [PubMed] [Google Scholar]
- 24.Kumar S., Tamura K., Nei M. MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief. Bioinform. 2004;5:150–163. doi: 10.1093/bib/5.2.150. [DOI] [PubMed] [Google Scholar]
- 25.Sabeti P.C., Reich D.E., Higgins J.M., Levine H.Z., Richter D.J., Schaffner S.F., Gabriel S.B., Platko J.V., Patterson N.J., McDonald G.J. Detecting recent positive selection in the human genome from haplotype structure. Nature. 2002;419:832–837. doi: 10.1038/nature01140. [DOI] [PubMed] [Google Scholar]
- 26.Scheet P., Stephens M. A fast and flexible statistical model for large-scale population genotype data: Applications to inferring missing genotypes and haplotypic phase. Am. J. Hum. Genet. 2006;78:629–644. doi: 10.1086/502802. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Akey J.M., Zhang G., Zhang K., Jin L., Shriver M.D. Interrogating a high-density SNP map for signatures of natural selection. Genome Res. 2002;12:1805–1814. doi: 10.1101/gr.631202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Ohashi J., Naka I., Patarapotikul J., Hananantachai H., Brittenham G., Looareesuwan S., Clark A.G., Tokunaga K. Extended linkage disequilibrium surrounding the hemoglobin E variant due to malarial selection. Am. J. Hum. Genet. 2004;74:1198–1208. doi: 10.1086/421330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Norman P.J., Abi-Rached L., Gendzekhadze K., Korbel D., Gleimer M., Rowley D., Bruno D., Carrington C.V., Chandanayingyong D., Chang Y.H. Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat. Genet. 2007;39:1092–1099. doi: 10.1038/ng2111. [DOI] [PubMed] [Google Scholar]
- 30.Single R.M., Martin M.P., Gao X., Meyer D., Yeager M., Kidd J.R., Kidd K.K., Carrington M. Global diversity and evidence for coevolution of KIR and HLA. Nat. Genet. 2007;39:1114–1119. doi: 10.1038/ng2077. [DOI] [PubMed] [Google Scholar]
- 31.Yawata M., Yawata N., McQueen K.L., Cheng N.W., Guethlein L.A., Rajalingam R., Shilling H.G., Parham P. Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression. Immunogenetics. 2002;54:543–550. doi: 10.1007/s00251-002-0497-x. [DOI] [PubMed] [Google Scholar]
- 32.Jiang K., Zhu F.M., Lv Q.F., Yan L.X. Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. Tissue Antigens. 2005;65:556–563. doi: 10.1111/j.1399-0039.2005.00412.x. [DOI] [PubMed] [Google Scholar]
- 33.Whang D.H., Park H., Yoon J.A., Park M.H. Haplotype analysis of killer cell immunoglobulin-like receptor genes in 77 Korean families. Hum. Immunol. 2005;66:146–154. doi: 10.1016/j.humimm.2004.10.013. [DOI] [PubMed] [Google Scholar]
- 34.Miyashita R., Tsuchiya N., Yabe T., Kobayashi S., Hashimoto H., Ozaki S., Tokunaga K. Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis. Arthritis Rheum. 2006;54:992–997. doi: 10.1002/art.21653. [DOI] [PubMed] [Google Scholar]
- 35.Yawata M., Yawata N., Draghi M., Little A.M., Partheniou F., Parham P. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J. Exp. Med. 2006;203:633–645. doi: 10.1084/jem.20051884. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Yabe T., Matsuo K., Hirayasu K., Kashiwase K., Kawamura-Ishii S., Tanaka H., Ogawa A., Takanashi M., Satake M., Nakajima K. Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation. Biol. Blood Marrow Transplant. 2008;14:75–87. doi: 10.1016/j.bbmt.2007.09.012. [DOI] [PubMed] [Google Scholar]
- 37.Kwiatkowski D.P. How malaria has affected the human genome and what human genetics can teach us about malaria. Am. J. Hum. Genet. 2005;77:171–192. doi: 10.1086/432519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Bleharski J.R., Li H., Meinken C., Graeber T.G., Ochoa M.T., Yamamura M., Burdick A., Sarno E.N., Wagner M., Rollinghoff M. Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science. 2003;301:1527–1530. doi: 10.1126/science.1087785. [DOI] [PubMed] [Google Scholar]
- 39.Hunt J.S., Petroff M.G., McIntire R.H., Ober C. HLA-G and immune tolerance in pregnancy. FASEB J. 2005;19:681–693. doi: 10.1096/fj.04-2078rev. [DOI] [PubMed] [Google Scholar]
- 40.Tan Z., Shon A.M., Ober C. Evidence of balancing selection at the HLA-G promoter region. Hum. Mol. Genet. 2005;14:3619–3628. doi: 10.1093/hmg/ddi389. [DOI] [PubMed] [Google Scholar]
- 41.Nakayama M., Underhill D.M., Petersen T.W., Li B., Kitamura T., Takai T., Aderem A. Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production. J. Immunol. 2007;178:4250–4259. doi: 10.4049/jimmunol.178.7.4250. [DOI] [PubMed] [Google Scholar]
- 42.Lichterfeld M., Kavanagh D.G., Williams K.L., Moza B., Mui S.K., Miura T., Sivamurthy R., Allgaier R., Pereyra F., Trocha A. A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cells. J. Exp. Med. 2007;204:2813–2824. doi: 10.1084/jem.20061865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Borges L., Cosman D. LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells. Cytokine Growth Factor Rev. 2000;11:209–217. doi: 10.1016/s1359-6101(00)00007-1. [DOI] [PubMed] [Google Scholar]
- 44.Kabalak G., Koch S., Dobberstein B., The Y.H., Matthias T., Schnarr S., Schmidt R.E., Witte T. Immunoglobulin-like transcripts as risk genes for autoimmunity. Ann. N Y Acad. Sci. 2007;1110:10–14. doi: 10.1196/annals.1423.002. [DOI] [PubMed] [Google Scholar]
- 45.Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol. 2003;2:117–127. doi: 10.1016/s1474-4422(03)00308-9. [DOI] [PubMed] [Google Scholar]